株探米国株
日本語 英語
エドガーで原本を確認する
false 0001145986 0001145986 2024-05-01 2024-05-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 01, 2024

 

 

 

ASPEN AEROGELS, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware 001-36481 04-3559972
(State or Other Jurisdiction
of Incorporation)
(Commission File Number) (IRS Employer
Identification No.)
     

 

30 Forbes Road

Building B

 
Northborough, Massachusetts 01532
(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (508) 691-1111

 

(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 


Title of each class
  Trading
Symbol(s)
 
Name of each exchange on which registered
Common Stock   ASPN   The New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 


Item 2.02 Results of Operations and Financial Condition.

 
On May 1, 2024, Aspen Aerogels, Inc. announced its financial results for the first quarter of 2024, which ended March 31, 2024, and also discussed business developments. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1.

 

The information set forth in the press release, except for the information set forth under the heading “2024 Financial Outlook” and under the heading “About Aspen Aerogels, Inc.,” together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 2.02 of this Current Report on Form 8-K.

 

Item 7.01 Regulation FD Disclosure.

 

The information set forth under the heading “2024 Financial Outlook” and under the heading “About Aspen Aerogels, Inc.,” together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 7.01 of this Current Report on Form 8-K.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit Number   Description
     
99.1   Press Release issued by Aspen Aerogels, Inc. on May 1, 2024
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)
     

 

The press release may contain hypertext links to information on our website. The information on our website is not incorporated by reference into this Current Report on Form 8-K and does not constitute a part of this Form 8-K.

 

The information contained in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

 


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      Aspen Aerogels, Inc.
       
Date: May 1, 2024 By: /s/ Ricardo C. Rodriguez
    Name: Ricardo C. Rodriguez
    Title: Chief Financial Officer and Treasurer

 

 

 

 

 

 

 

 

 

 

EX-99.1 2 exh_991.htm EXHIBIT 99.1

 

Exhibit 99.1 

Aspen Aerogels, Inc. Reports First Quarter 2024 Financial Results and Recent Business Highlights

 

For Immediate Release

 

$94.5 million in company revenue drove 37% gross profit margins and $12.9 million of Adjusted EBITDA

Raising 2024 baseline Adjusted EBITDA outlook by 83%

Expecting positive net income for 2024

 

NORTHBOROUGH, Mass., May 1, 2024 — Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”), a technology leader in sustainability and electrification solutions, today announced financial results for the first quarter of 2024, and discussed recent business developments.

 

Total revenue for the first quarter of 2024 was $94.5 million, compared to $45.6 million in the first quarter of 2023. Net loss was $1.8 million, compared to a net loss of $16.8 million in the first quarter of 2023. Net loss per share was $0.02, compared to a net loss per share of $0.24 in the first quarter of 2023.

 

Adjusted EBITDA for the first quarter of 2024 was $12.9 million, compared to $(13.9) million in the first quarter of 2023. A reconciliation of net loss to non-GAAP Adjusted EBITDA is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."

 

Recent Business Highlights & Quarterly Performance

 

· Company revenue of $94.5 million, up 12% quarter-over-quarter (QoQ) and 107% year-over-year (YoY)
- Thermal Barriers: $65.4 million of revenue, up 23% QoQ and 459% YoY
- Energy Industrial: $29.1 million of supply constrained revenue,  down 7% QoQ and down 14% YoY
· Energy Industrial segment on path to deliver over $150 million of revenue in 2024, shipped $14.6 million of revenue from our external manufacturing facility in Q1
· Delivered gross margins of 37%, a 2-percentage point improvement QoQ and 26-percentage point improvement YoY
· Adjusted EBITDA of $12.9 million, a $3.8 million improvement or 42% QoQ and $26.9 million improvement YoY
· Operating income of $2.4 million, a $1.1 million improvement or 76% QoQ and $21.3 million improvement YoY
· Ended first quarter of 2024 with cash and equivalents of $101.5 million
· Received coveted Automotive News PACE Award for PyroThin® cell-to-cell (C2C) barrier platform; Automotive News’ PACE program is recognized globally as the most prestigious innovation award for automotive suppliers
· Also presented  with a PACE Innovation Partnership Award, recognizing Aspen’s collaboration with General Motors centered on our  PyroThin C2C barriers as the thermal runaway solution for GM’s Ultium battery platform

 

“We continue to execute the transition of our Energy Industrial products to our external manufacturing facility and dedicate our manufacturing plant in East Providence to the production of aerogel for EV thermal barriers. We believe the Q1 results further demonstrate that we have the capability with existing assets and supply arrangements to deliver $650 million of annual revenue with at least 35% gross margins and 25% Adjusted EBITDA margins,” commented Don Young, Aspen’s President and CEO. "We remain deeply engaged with a growing list of automotive OEMs and battery cell manufacturers and have strong conviction that we are providing a unique solution to a very challenging problem. We remain focused on scaling the five OEM awards that we have in hand alongside maximizing our Energy Industrial business.”

 

Updated 2024 Financial Outlook

 

Aspen updated its 2024 full year outlook as follows:

 

($ in millions, except per share amounts)
Metric Prior 2024 Outlook Updated 2024 Outlook Delta % Improvement

Revenue

YoY Growth

>350

47%

>380

59%

30

12%

9%

26%

Adjusted EBITDA >30 >55 25 83%
Net Income (Loss) >(23) >2 25 109%
Earnings Per Share >(0.30) >0.03 0.33 109%

 

 


The Company's 2024 outlook assumes depreciation and amortization of $30 million, stock-based compensation expense of $14 million, other (income) expense and income tax expense of $9 million, and weighted average shares outstanding of 75.8 million for the full year.

 

A reconciliation of net loss to non-GAAP Adjusted EBITDA for the 2024 financial outlook is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading “Non-GAAP Financial Measures.”

 

Ricardo C. Rodriguez, Chief Financial Officer and Treasurer noted, “We added $10 million of revenue quarter over quarter, a 12% increase. More importantly, we increased Adjusted EBITDA by 42% quarter over quarter, to $12.9 million, and operating income increased by 76%, further validating  the scalability of our operations. We are increasingly optimistic about our outlook for the year as our main automotive OEM customers capture their fair share of the EV market, and our Energy Industrial customers benefit from incremental supply through our external manufacturing facility.” Mr. Rodriguez added, “These elements, combined with our team’s continued execution, enable us to raise our 2024 baseline Adjusted EBITDA outlook by 83%, to $55 million on $380 million of revenue, and to anticipate positive net income for the year.”

 

Aspen may incur, among other items, additional charges, realize gains or losses, incur financing costs or interest expense, or experience other events in 2024, including those related to the planned capacity expansion, supply chain disruptions, or further cost inflation, that could cause actual results to vary materially from this outlook. See Special Note Regarding Forward-Looking and Cautionary Statements below.

 

Last Twelve-Month Financial Comparison 

 

A comparison of key financial metrics for the trailing twelve-month periods ended March 31, 2023 and 2024:

 

($ in millions)
Metric LTM Q1 2023 LTM Q1 2024 Delta % Improvement
Revenue 188 288 100 53%

Gross Profit

% Margin

12

6%

87

30%

75 629%

Adjusted EBITDA

% Margin

(60)

(32%)

4

1%

64 107%

Operating Income

% Margin

(80)

(42%)

(28)

(10%)

52 65%

Net Loss

% Margin

(80)

(43%)

(31)

(11%)

49 61%
Total CAPEX 213 152 (61) 29%

 

Conference Call and Webcast Notification

 

A conference call with Aspen management to discuss first quarter 2024 results and recent business developments will be held Thursday, May 2, 2024 at 8:30 a.m. ET. During the call, management will respond to questions concerning, but not limited to, Aspen's financial performance, business conditions, and financial outlook. Management's discussion and responses could contain information that has not been previously disclosed.

 

Shareholders and other interested parties may call +1 (833) 470-1428 (domestic) or +1 (929) 526-1599 (international) and reference conference ID "917527" to participate in the conference call. In addition, the conference call and an accompanying slide presentation will be available live as a listen-only webcast hosted at the Investors section of Aspen's website, www.aerogel.com.

 

Following the live event, an archived version of the webcast will be available on Aspen's website for convenient on-demand replay for at least a year. A copy of this press release is posted in the Investors section on Aspen's website.

 

Non-GAAP Financial Measures

 

In addition to providing financial measurements based on generally accepted accounting principles in the United States of America ("GAAP"), Aspen provides an additional financial metric that is not prepared in accordance with GAAP ("non-GAAP"). The non-GAAP financial measure included in this press release is Adjusted EBITDA. Management uses this non-GAAP financial measure, in addition to GAAP financial measures, as a measure of operating performance because the non-GAAP financial measure does not include the impact of items that management does not consider indicative of Aspen's core operating performance. In addition, management uses Adjusted EBITDA (i) for planning purposes, including the preparation of Aspen's annual operating budget, (ii) to allocate resources to enhance the financial performance of its business, and (iii) as a performance measure under its bonus plan.

 

 


Management believes that this non-GAAP financial measure reflects Aspen's ongoing business in a manner that allows for meaningful comparisons and analysis of trends in its business, as it excludes expenses and gains not reflective of Aspen's ongoing operating results or that may be infrequent and/or unusual in nature. Management also believes that this non-GAAP financial measures provides useful information to investors in understanding and evaluating Aspen's operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. This non-GAAP measure may not be comparable to similarly titled measures presented by other companies.

 

The non-GAAP financial measure does not replace the presentation of Aspen's GAAP financial results and should only be used as a supplement to, not as a substitute for, Aspen's financial results presented in accordance with GAAP. In this press release, Aspen has provided a reconciliation of Adjusted EBITDA to net loss, the most directly comparable GAAP financial measure. Management strongly encourages investors to review Aspen's financial statements and publicly filed reports in their entirety and not rely on any single financial measure.

 

About Aspen Aerogels, Inc.

 

Aspen is a technology leader in sustainability and electrification solutions. The Company's aerogel technology enables its customers and partners to achieve their own objectives around the global megatrends of resource efficiency, e-mobility, and clean energy. Aspen's PyroThin® products enable solutions to thermal runaway challenges within the electric vehicle ("EV") market. Aspen Battery Materials, the Company's carbon aerogel initiative, seeks to increase the performance of lithium-ion battery cells to enable EV manufacturers to extend the driving range and reduce the cost of EVs. The Company's Cryogel® and Pyrogel® products are valued by the world's largest energy infrastructure companies. Aspen's strategy is to partner with world-class industry leaders to leverage its Aerogel Technology Platform® into additional high-value markets. Aspen is headquartered in Northborough, Mass. For more information, please visit www.aerogel.com.

 

Special Note Regarding Forward-Looking and Cautionary Statements

 

This press release and any related discussion contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to Aspen’s 2024 financial outlook. These statements are not historical facts but rather are based on Aspen’s current expectations, estimates and projections regarding Aspen's business, operations and other factors relating thereto, including with respect to Aspen’s 2024 financial outlook. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates," "outlook," “assumes,” “targets,” “opportunity,” and similar expressions are used to identify these forward-looking statements. Such forward-looking statements include statements regarding, among other things, Aspen’s expectations about capacity, revenue, revenue capacity, backlog, costs, expenses, profitability, cash flow, gross profit, gross margin, operating margin, net loss, Adjusted EBITDA, Adjusted EBITDA margin and related decreases, improvements, timing, variability or trends; beliefs about higher than expected demand from the EV market and how it may enable a path to profitability, expectations about improvement in ability to absorb fixed costs and reduction of conversion costs as a percentage of sales and the same leading to target revenue capacity and gross margins and Adjusted EBITDA margins; Aspen’s expectations regarding the planned second manufacturing plant in Georgia (“Plant II”), the extended construction and commissioning timeframe for Plant II, Aspen’s efforts to manage the construction of Plant II to align with our expectations of demand from EV customers, and the use of contract manufacturers to meet demand from Energy Industrial customers; beliefs about the general strength, weakness or health of Aspen’s business; acceleration in demand; beliefs about current or future trends in the energy, energy infrastructure, chemical and refinery, LNG, sustainable building materials, EV thermal barrier, EV battery materials or other markets and the impact of these trends on Aspen’s business; beliefs about the strength, effectiveness, productivity, costs, profitability or other fundamentals of Aspen’s business; beliefs about the role of Aspen’s technology and opportunities in the electric vehicle market; beliefs about Aspen’s ability to provide and deliver products and services to electric vehicle customers; beliefs about content per vehicle, revenue, costs, expenses, profitability, investments or cash flow associated with Aspen’s electric vehicle opportunities, including the EV thermal barrier business; beliefs about revenue growth and profitability; beliefs about the performance of PyroThin® including its ability to mitigate the propagation of thermal runaway in electric vehicles; beliefs about Aspen’s ability to expand the market for PyroThin®, to achieve design wins, to commence shipments of production parts, and to become an industry standard solution for thermal runaway management; beliefs about Aspen’s thermal barrier design, prototype, quoting and assembly activities; and expectations about the cost of the capital projects, including Plant II; and beliefs about the Company’s pending application with the DOE seeking a loan pursuant to the DOE LPO's ATVM. All such forward-looking statements are based on management’s present expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the following: inability to execute the growth plan, inability to continue construction of Plant II and to do so at a cost consistent with Aspen’s estimates and aligned with Aspen’s expectations of demand from our EV customers; the right of EV thermal barrier customers to cancel contracts with Aspen at any time and without penalty; any costs, expenses, or investments incurred by Aspen in excess of projections used to develop pricing under the contracts with EV thermal barrier customers; Aspen’s inability to create customer or market opportunities for, including PyroThin®; any other battery performance and safety products, battery materials or for other new products developed from Aspen’s aerogel technology; any disruption or inability to achieve expected capacity levels in any of the three existing production lines in East Providence, RI or the Mexico assembly facility or at any contract manufacturer; any failure to enforce any of Aspen’s patents; the general economic conditions and cyclical demands in the markets that Aspen serves; and the other risk factors discussed under the heading “Risk Factors” in Aspen’s Annual Report on Form 10-K for the year ended December 31, 2023 and filed with the Securities and Exchange Commission (“SEC”) on March 7, 2024, as well as any updates to those risk factors filed from time to time in Aspen’s subsequent periodic and current reports filed with the SEC. All statements contained in this press release are made only as of the date of this press release. Aspen does not intend to update this information unless required by law. 

 

 


Investor Relations & Media Contacts:

 

Neal Baranosky

Phone: (508) 691-1111 x 8

nbaranosky@aerogel.com

 

Georg Venturatos / Jared Gornay

Gateway Group

ASPN@gateway-grp.com

Phone: (949) 574-3860

 

 

 

 

 

 

 

 

 

 

 

 

 

 


ASPEN AEROGELS, INC.

Condensed Consolidated Balance Sheets

(Unaudited and in thousands)

 

         
    March 31,   December 31,
    2024   2023
    (In thousands)
Assets        
Current assets:                
Cash and cash equivalents   $ 101,461     $ 139,723  
Restricted cash     157       248  
Accounts receivable, net     84,029       69,995  
Inventories     45,750       39,189  
Prepaid expenses and other current assets     23,708       17,176  
Total current assets     255,105       266,331  
Property, plant and equipment, net     422,736       417,227  
Operating lease right-of-use assets     16,824       17,212  
Other long-term assets     3,324       2,278  
Total assets   $ 697,989     $ 703,048  
Liabilities and Stockholders’ Equity                
Current liabilities:                
Accounts payable   $ 44,713     $ 51,094  
Accrued expenses     12,762       22,811  
Deferred revenue     3,130       2,316  
Finance obligation for sale and leaseback transactions     1,206       -  
Operating lease liabilities     1,769       1,874  
Total current liabilities     63,580       78,095  
Convertible note - related party     118,030       114,992  
Finance obligation for sale and leaseback transactions long-term     3,556       -  
Operating lease liabilities long-term     21,620       21,906  
Total liabilities     206,786       214,993  
Stockholders’ equity:                
Total stockholders’ equity     491,203       488,055  
Total liabilities and stockholders’ equity   $ 697,989     $ 703,048  

 

 

 

 


ASPEN AEROGELS, INC.

Consolidated Statements of Operations

(Unaudited and in thousands, except share and per share data)

 

    Three Months Ended
    March 31,
    2024   2023
    (In thousands, except
share and per share data)
         
Revenue   $ 94,501     $ 45,586  
Cost of revenue     59,358       40,500  
Gross profit     35,143       5,086  
Operating expenses:                
Research and development     4,489       4,099  
Sales and marketing     8,303       7,713  
General and administrative     17,213       12,182  
Impairment of equipment under development     2,702       -  
Total operating expenses     32,707       23,994  
Income (loss) from operations     2,436       (18,908 )
Other income (expense)                
Interest expense, convertible note - related party     (3,038 )     (275 )
Interest income (expense)     (477 )     2,387  
Total other income (expense)     (3,515 )     2,112  
Loss before income tax expense     (1,079 )     (16,796 )
Income tax expense     (756 )     -  
Net loss   $ (1,835 )   $ (16,796 )
Net loss per share:                
Basic and diluted   $ (0.02 )   $ (0.24 )
Weighted-average common shares outstanding:                
Basic and diluted     75,762,893       69,162,739  

 

Analysis of Cash Flow

 

The following table summarizes our cash flows for the periods indicated.

 

    Three Months Ended
    March 31, 2024
    (In thousands)
Net cash provided by (used in):        
Operating activities   $ (17,749 )
Investing activities     (25,863 )
Financing activities     5,259  
Net (decrease) increase in cash     (38,353 )
Cash, cash equivalents and restricted cash at beginning of period     139,971  
Cash, cash equivalents and restricted cash at end of period   $ 101,618  

 

Reconciliation of Non-GAAP Financial Measures

 

The following tables present a reconciliation of the non-GAAP financial measure included in this press release to the most directly comparable GAAP measure:

 

Reconciliation of Adjusted EBITDA to Net Loss

 

We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, which occur from time to time and which we do not believe are indicative of our core operating performance.

 

 


For the three months ended March 31, 2024 and 2023:

 

    Three Months Ended
    March 31,
    2024   2023
    (In thousands)
Net loss   $ (1,835 )   $ (16,796 )
Depreciation and amortization     5,786       2,704  
Stock-based compensation     4,706       2,267  
Other expense (income)     3,515       (2,112 )
Income tax expense     756       -  
Adjusted EBITDA   $ 12,928     $ (13,937 )

 

For the trailing twelve months ended March 31, 2024 and 2023:

    Last Twelve Months
    March 31,
    2024   2023
    (In thousands)
Net loss   $ (30,850 )   $ (80,050 )
Depreciation and amortization     18,400       9,797  
Stock-based compensation     13,393       9,824  
Other expense     2,235       521  
Income tax expense     756       -  
Adjusted EBITDA   $ 3,934     $ (59,908 )

 

For the 2024 full year financial outlook:

 

    Year Ending
    December 31, 2024
    Current   Prior
    (In thousands)
Net income (loss)   $ 2,000     $ (23,000 )
Depreciation and amortization     30,000       30,000  
Stock-based compensation     14,000       14,000  
Other expense, net and income tax expense     9,000       9,000  
Adjusted EBITDA   $ 55,000     $ 30,000